Highlights
NASDAQ: REGN       Regeneron Pharmaceutical
Last Price Today's Change   Day's Range   Trading Volume
372.09   -0.23 (0.06%)  369.47 - 375.40  237,567

Overview

Avg Volume (4 weeks):0
4 Weeks Range:363.39 - 401.21
52 Weeks Range:325.35 - 452.96
Average Price Target: 430.00
Price Target Upside/Downside: +57.91

Headlines



No recent Headlines for this stock.


Business Background

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.

  Be the first to like this.
 


 

4637  2349  596  743 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CSQ 11.42+0.01 
 BNCL 17.00+0.40 
 GALT 3.13-0.14 
 BBRY 9.195+0.005 
 NUGT 7.82-0.35 
 X 23.275-7.835 
 TWTR 15.995+1.335 
 BAC 24.07+0.09 
 SPY 239.19+0.64 
 EEM 40.066-0.134 
Partners & Brokers